cytosine has been researched along with dihydropyridines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greig, NH; Khamnei, S; Kinjo, J; Torrence, PF | 1 |
| Adams, ND; Antony-Debre, I; Bantscheff, M; Barreyro, L; Bartholdy, B; Brady, P; Cartier, J; Carvajal, L; Christopeit, M; Concha, N; Drewes, G; Duraiswami, C; Faelth-Savitski, M; Gao, EN; Groy, A; Joberty, G; Kao, YR; Maciejewski, J; Makishima, H; McCabe, MT; Mitchell, K; Narayanagari, SR; Okoye-Okafor, UC; Paietta, E; Pietrak, B; Qi, H; Quinn, C; Reif, AJ; Rendina, AR; Rominger, C; Schmidt, SJ; Schwartz, B; Smallwood, A; Steidl, U; Verma, A; Wang, HR; Wiggall, KJ; Will, B; Zhao, H | 1 |
2 other study(ies) available for cytosine and dihydropyridines
| Article | Year |
|---|---|
Synthesis and pharmacokinetics of a dihydropyridine chemical delivery system for the antiimmunodeficiency virus agent dideoxycytidine.
Topics: Animals; Biotransformation; Brain; Cytosine; Cytosol; Dihydropyridines; Drug Carriers; HIV; HIV-1; Hydrolysis; Kinetics; Male; Oxidation-Reduction; Prodrugs; Rats; Rats, Wistar; Zalcitabine | 1993 |
New IDH1 mutant inhibitors for treatment of acute myeloid leukemia.
Topics: Allosteric Regulation; Allosteric Site; Animals; Cell Differentiation; Cell Line, Tumor; CpG Islands; Crystallography, X-Ray; Cytosine; Dihydropyridines; DNA Methylation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Granulocytes; Humans; Isocitrate Dehydrogenase; Kinetics; Leukemia, Myeloid, Acute; Male; Mice; Models, Molecular; Mutation; Neoplastic Stem Cells; Primary Cell Culture; Protein Binding; Pyrazoles; Xenograft Model Antitumor Assays | 2015 |